Hi DS, this is from Nick Woolf...
Hi Tony,
This is a well thought out post. I'm reluctant to comment specifically but I would remind the market that we are aiming to close deals in the near term that have upfronts. Also, we are hoping for substantial payments from Pfizer and Roche/Genentech if they decide to exercise their options to license. The next scheduled payment from Janssen is chunky and comes on the 12-month anniversary.
Nick
Ann: Phylomer licenced to Le metier de Beaute , page-47
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.0¢ | $297.5K | 2.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1372418 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 390472 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |